On June 30th, Skyhawk Therapeutics shared a press release with new twelve-month data from the ongoing Phase 1/2 trial of ...

Skyhawk Therapeutics, Inc., a clinical-stage biotechnology company developing novel small molecule therapies designed to modulate RNA targets, announces cUHDRS subcomponent data from the twelve-month ...

Adults who eat more ultra-processed foods show measurably slower thinking on standardized cognitive tests, and the effect ...

On May 27, the American Cancer Society published updated screening guidelines for colorectal cancer, officially adding Guardant Health’s FDA-approved Shield blood test to its list of approved ...

eMultiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, ...

Background Cognitive impairment is common in multiple sclerosis (MS), and visual memory impairments are increasingly considered clinically important, yet still underappreciated. Objective To compare ...

Background Tuberous sclerosis complex (TSC) is a genetic disease characterised by the growth of benign tumours. The Tuberous sclerosis Associated Neuropsychiatric Disorders (TAND) Checklist is used to ...

Parkinson’s disease (PD) can be classified into brain-first and body-first subtypes based on the initial site of α-synuclein pathology. Postmortem studies further suggest that body-first PD may be ...

Depression and anxiety in patients with Huntington disease (HD) were associated with an increased risk for HD progression and all-cause mortality, but antidepressant initiation was linked to a reduced ...

Please provide your email address to receive an email when new articles are posted on . No differences were found between older and younger patients in six other cognitive subdomains. Screening ...